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area x v should exceed Q, We tested thin In vitro using 3D reconstructions 
of digital color Doppler In 18 rotated views. ~i~h circular ortflcea (0,2-0,8 cm ~ 
arcea) studied at 7 Qe (20-140 ml/s) nnd 8 Nyqulsts (336 stages) In rclatlvoly 
confined and unconfined chambers (2.0 and 5,7 cm diameters), 
Results:In tlte largo chamber, Q calculated aa 3D aruo ~ v agreed well with 
actual v~luea. With oonflnement and Increasing Q, prominent overestimation 
occurred except near the orifice at high Nyqulste, 
Conclusion: The PISA technique c~n aeverly overcatlmnt(~ flow rote In 
confined ~etllng~, whore basic assumptions Arc violated, The potential for 
this effeot should be considered for proximal rcgurgllant Ilowe within a small 
ventricle, sortie reel. or steeled prosthotlo valve, 
~ O a n  Vla=oua Eff~ct= Explain Cardlao Output 
Related Changes In Gorlln Equation Aortlo Valve 
Area In Aort la  Stenoala?  
R,O, Rllkln, 't~tt~l University School of Mcclicine, Boston; Mt]~s, and L3,1ysfafe 
M~Mtcal Cerlh~r, Sprlngftekt, Mass, USA 
Conlrovomy parststs over whether cardla~ output (Q) dependency of Qotlin 
equation (GE) valve arcs (Ar) in settle mlenoats (AS) in dub to visc~ostty or 
changes In anatomic entice At, We devised a numencal model el puls~tda 
flow in which total tnManf~noat~s gradient wan the sum of the convective, the 
pmsmlrc recover/~nd the vlaoousterms; APmlm - (1/2)~ (V~ -+ V~) + i~ Vd (Vd 
- V i) + KV" where p, d, and j denote, mspemtwely, the rcgibns proximal and 
dlslal to the atenosla, and at the high velocity jet, V = flow velocity = Q/fL ~ = 
density, K and ,+ arc parametam representing viscous effects We determined 
K and ~v for various slenoses by lilting &P~m,~ to published cuwes el entice 
diseftatge coefficients, adlusllng K and w to obtain the best fit, We then used 
these vahle~ of K and ~, to calculate apparent GE valve Ar as a function of 
Q: A~+~mm ,~ (Q/$ET)/[44,4~/=~Pem.~] where SET =~ systolic oiection time end 
o, m I' ~-~ P~mmdl, which is the mean systolic gradient for an assumed 
sysleli(~ time.velocity prcfllt~ nnd true valve arcs (TVA), 
R~sul~: (areas In sq ca) 
012345678 
Q (Umln, pul~atile flow) 
Conclusions; ( t .) GE fir falls with do, creasing Q due to viscomt'y but within 
the physiologic range el Q, the elfocf is too small to explain the si:'e of 
Q.rotato~l Ar changes reported in AS, (2.) Anatomic changes in Ar erobably 
explain most of the nportod flew dependency of the Gorlin equal=on. 
• Comparison Between Aortic Valve Resistance and 
Ori f ice Area In Assess ing  Aor t i c  Stenos la  Severity 
F, Antonini-Canfonn, F, Ribichini t , P, Faggiano, A. D'Aloia, Y. Forroro ~ ,
C, Bu,elh, F, Cervesato, O, Pavan, G,L. Nicotosi, D. ZanutbeL Carchologia. 
ARC. Pom~enone, Italy; t Cardlo/og~a. ARC, Cuneo, Italy 
Backgnund: Aortic valve resistance (AVR) has been recently emphasized 
as a possible flow-independent index of aortic stenosis (AS) seventy. Then 
~ro, however, few studies in small groups of patients (pts). in whmh AVR 
has Lt~on compand to aortic valve aria (AVA) in order to establish reliable 
cut.De values of severity. Furthermore it is yet unknown if fiVR may provide 
adjunctive clinical information in the management of pts with AS, 
Methods: fiVA and AVR were determined by means of cardiac catheter- 
ization in 359 consecutive pts with AS (232 males, 127 females aged 67 ± 
8 years), The elation of both AVA and AV: ~ with the NYHA class was then 
studied. 
Results: Mean AVA was 0.65 ± 0.22 cm ~, mean AVR was 491 ~ 241 dyne 
x sec x cm s, with significant inverse correlation (r = -0.65, p < 0,0001)+ 
Using th~ AVR cut-off ~_300 dyne ,~ sec × cm 5 to identi~ pts with fiVA ~0.8 
cm "~ we observed 263 true positive, 20 lalse positive, 32 false negative, 44 
true negative (sensitivity 89%, specificity 69%). In pts with NYHA class, I-II 
end Ill-IV mean AVA was 0,66 ± 0.19 and 0.61 ± 0.28 cm 2 respectively (p = 
as). AVR instead was 464 ± 201 and 569 ± 317 in the two groups respectively 
(p < 0.001). 
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Conclusfon: tn pts with AS, an AVR cut-off vall.~e 2300 dyn~ ~. so(; ,. 
cm s allows identification of an AVA ~0,6 cm ~ with good sensitivity aed laidy 
good speeili(:ity, In our Population &VR, a functional inde~ ol hemodynam¢ 
impairment, wan, unlike oeliee arcs, eigni|teantty rcl~ted fO NYHf  rise:,. As a 
consequence AVR seams to offer useful adluoctive clinical infom~tr~4~ fn pts 
With AS 
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~ Post -Operat ive  At r ia l  F ibr i l lat ion - A Randomized 
1Ylal o f  Metopre lo l ,  F lacalnlde,  and  P lacebo  
J. Dy, 1". Jayasundera, D. Kapad+a, C. Cupormsn, G. Whitman. V. OISesa+ 
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This stuffy compared Mefoprolol, Flecainido and placebo as prophylaxis against 
atnal fibnllafion (A.F.). 201 patients who had isolated coronary artery bypass 
surgery from January t 995 to May 1997 were randomized in a double-blinded 
fashion to either ot the three eels. Exclusion cnfena include EF <30%, pnor 
atnat or ventncular arrhythmia, severe COPD, serum Cr :-2.0, and/or seven 
bradycardia, The randomized drug was given after extubatlon and continued 
till 24 Q pnor to discharge. All patients wen mustered continuously on AMES 
system. 24 of 66 placebo patients (36%), 10 of 67 Metoprolol patients (16%), 
and 15 of 68 Ftecainide patients (22%) had A.F There was significant Cffer- 
ence (p = 0.0047) between placebo and Lopressor and a strong trend between 
placebo and Flccainido (p = 0.069). No slgmficant difference (p = 0.24) was 
soon between Flecainide and Lopressor. No significant difference was noted 
in side effect profile. In summary, Flecainido is less eltccfwe than Metopnlol 
in pnvenfing post-operative A.F., but may sea's as an alternative prophylactic 
agent. 
• Intermediate-term Results From 
Carpent ler -Ec lwards lY Icusp id  Valve Repair 
K,P. Landolfo, D,D. Glower. Y.-Y. Cen, RD. Davis, J. Jaggers. J.K. Harrison, 
TM. Bashoro+ Duke University. Durham. NC. USA 
Few d3ta exist regarding the durability and morbidity of tncusptd valve repair 
with the Carpentier-Edwards (CE) nng prosthesis. Therefore, a retrospective 
review was pedormed of 40 consecutive patients undergoing CE tricuspid 
repair. Follow-up was 90% complete and extended to 7 years. Mean age 
was 57 + 17 years. Concurrent operations included coronary bypass in 3/40 
(8%) and mitral or aortic valve operation in 32/40 (80%). Pnvious median 
stemotomies were present in 16/40 (40%)+ Thirty day survival was 91 + 5%. 
In-hospital morbidity was low with stroke, prolonged ventilation, or low cardiac 
output occurring in 7•40 (18%). New permanent pacemaker was nquired 
in 3/40 (8%). Survival was 88 ~ 5% at 1 year and 63 ± 16% at 5 years. 
No patient nquired tncuspid valve reoperation, and freedom from significant 
tricuspid valw dysfunction w3s 94 ± 6% at 5 years. Four patients developed 
late moderate tricuspid ngurgitation generally due to relative oversizing of the 
tricuspid ring. but all 4 patients ascended well to medical therapy. 
Carpentier-Edwards ring repair of the tricuspid valve appears to be durable. 
involves low morbidity in relatively high risk patients, and should be considered 
in patients with moderate or severe tricuspid ngurgitation. Caution should be 
taken to avoid ring oversizing. 
